CD8A and neoplasm: The results showed that patients in the high- and low-risk groups had significantly different levels of activated dendritic cells (aDCs), CD8+ T cells, immature dendritic cells (iDCs), mast cells, macrophages, T helper cells, T follicular helper (Tfh) cells, T helper type 1 (Th1) cells, T helper type 2 (Th2) cells, and tumor-infiltrating lymphocytes (TILs) (Fig. 11a).